ABO-101 clinical trials

Phase 1/2 Study of ABO-101 in Primary Hyperoxaluria Type 1 (redePHine)

This study is testing a new medicine, ABO-101, for people with a rare kidney condition called Primary Hyperoxaluria Type 1 (PH1). It looks at how safe the medicine is, how well the body handles it, and if it could help. It involves both adults and children.